Ad is loading...
FAEVX
Price
$26.26
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
VVIAX
Price
$69.72
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
Ad is loading...

FAEVX vs VVIAX

Header iconFAEVX vs VVIAX Comparison
Open Charts FAEVX vs VVIAXBanner chart's image
Fidelity Advisor Equity Value Z
Price$26.26
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index Adm
Price$69.72
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
FAEVX vs VVIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FAEVX vs. VVIAX commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FAEVX is a Buy and VVIAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 184B vs. FAEVX (215M). VVIAX pays higher dividends than FAEVX: VVIAX (2.36) vs FAEVX (1.55). FAEVX was incepted earlier than VVIAX: FAEVX (8 years) vs VVIAX (24 years). FAEVX is a more actively managed with annual turnover of: 29.00 vs. VVIAX (10.00). FAEVX has a lower initial minimum investment than VVIAX: FAEVX (0) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 26.09 vs. FAEVX (16.84). VVIAX return over 5 years is better than : 53.09 vs. FAEVX (42.80).
FAEVXVVIAXFAEVX / VVIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years24 years-
Gain YTD14.52219.67274%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets215M184B0%
Annual Yield % from dividends1.552.3666%
Returns for 1 year16.8426.0965%
Returns for 3 years13.6224.7755%
Returns for 5 years42.8053.0981%
Returns for 10 yearsN/A112.26-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DOLE15.260.19
+1.26%
Dole plc
NCNO40.450.37
+0.92%
nCino
SGHT3.760.03
+0.80%
Sight Sciences
VICI32.370.25
+0.78%
VICI Properties
SABS3.070.01
+0.33%
SAB Biotherapeutics